跳至主要内容
临床试验/IRCT20221111056469N1
IRCT20221111056469N1尚未招募未知

Evaluation the effectiveness of the Curcumin as add-on to dienogest in patients with endometriosis.

Zahedan University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Women aged 18 to 45 years experiencing pain associated with endometriosis proven by ultrasound and examination and history
  • No previous history of using hormonal agents
  • Candidate to receive dinogest

排除标准

  • Pregnancy or breastfeeding
  • The need for surgery after the intervention
  • Previous use of hormonal agents (such as GnRH agonists for 6 months, progestins, dienogest or danazol for 3 months or oral contraceptives for 1 month before the intervention)
  • Abnormal findings in women's examination
  • Abnormal cervical cytology smear in the last 3 months
  • Taking narcotic painkillers before surgery on a daily basis for 2 weeks before surgery
  • Additional surgeries performed or malignancy

研究者

发起方
Zahedan University of Medical Sciences

相似试验